Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 4.85 CHF -6.73% Market Closed
Market Cap: 178.7m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

P/OCF
Price to OCF

-3
Current
-2.2
Median
23.4
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-3
=
Market Cap
184m CHF
/
Operating Cash Flow
-62m CHF
All Countries
Close
Market Cap P/OCF
CH
Molecular Partners AG
SIX:MOLN
184m CHF -3
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 050.3
US
Abbvie Inc
NYSE:ABBV
300.2B USD 18.2
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 21.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD -135.5
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 11.4
US
Epizyme Inc
F:EPE
94.1B EUR -476.6
AU
CSL Ltd
ASX:CSL
137.3B AUD 32.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 20.7
US
Seagen Inc
F:SGT
39.3B EUR -76.9
NL
argenx SE
XBRU:ARGX
34.1B EUR -138.6
 
CH
Molecular Partners AG
SIX:MOLN
Average P/OCF: 20.9
Negative Multiple: -3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 050.3
US
Abbvie Inc
NYSE:ABBV
18.2
US
Amgen Inc
NASDAQ:AMGN
21.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -135.5
US
Gilead Sciences Inc
NASDAQ:GILD
11.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -476.6
AU
CSL Ltd
ASX:CSL
32.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
20.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -76.9
NL
argenx SE
XBRU:ARGX
Negative Multiple: -138.6

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More